Olema Pharmaceuticals, Inc. (OLMA) Tops Q1 EPS by 18c

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) reported Q1 EPS of ($0.36), $0.18 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Olema Pharmaceuticals, Inc. (OLMA) click here.

You May Also Be Interested In

• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Active options: AVGO MSTR PLTR SNDK SMCI NBIS MSFT META GOOGL NU NFLX ONDS
• New Mexico gas pipeline for Oracle data center delayed to 2027